Smith B K, Barker K, Schork M A, Kluger M J
University of Michigan, Ann Arbor, USA.
Appetite. 1994 Dec;23(3):219-30. doi: 10.1006/appe.1994.1055.
Experimental tumors induce a decline in food intake that may derive from changes in taste or the development of taste aversions. The preferences of tumor-bearing (TB) and non-tumor-bearing (NTB) rats for five chemicals (three palatable and two aversive taste stimuli) were studied in an animal model of experimental cancer employing the methylcholanthrene (MCA) sarcoma. In protocol 1, five groups of Fischer 344 rats were given 23-h, two-bottle preference tests (taste solution vs. water) daily from day 3 after tumor implantation until spontaneous death occurred. Both NTB and TB rats avoided quinine hydrochloride and hydrochloric acid solutions throughout the experiment indicating that tumor growth produced no disruption in the animals' perception of these normally aversive tastes. In both groups, preference for sucrose (88% to 97%) and saccharin (75% to 93%) remained high until days 22 and 17 respectively, but tended to decline with advanced tumor growth. In both cases, a reduction in total calorie intake preceded the changes in sucrose or saccharin preference by several days. With or without a tumor, rats exhibited approximately 50% preference for NaCl at all times. In protocol 2, a four-bottle preference test (sucrose vs. saccharin vs. NaCl vs. water) was administered before tumor implantation and again 3 weeks later when a decline in food intake was evident. Both TB and NTB rats displayed a dominant preference for sucrose over saccharin, NaCl, and water at the pre- and posttests. However, a comparison of the difference scores (pre- minus postimplantation) of NTB and TB rats showed a small but significant suppression of TB animals' preference for sucrose. The altered preferences for sweet but not salt taste stimuli suggest that food-related taste cues may be more susceptible to the development of taste aversions during cancer. However the contribution of taste changes to the anorexia of cancer remains unclear and it is possible that the changes in taste preference may be secondary to the reduction in food intake.
实验性肿瘤会导致食物摄入量下降,这可能源于味觉变化或味觉厌恶的形成。在使用甲基胆蒽(MCA)肉瘤的实验性癌症动物模型中,研究了荷瘤(TB)和未荷瘤(NTB)大鼠对五种化学物质(三种可口味觉刺激物和两种厌恶味觉刺激物)的偏好。在方案1中,从肿瘤植入后第3天开始,每天对五组Fischer 344大鼠进行23小时的双瓶偏好测试(味觉溶液与水),直至自发死亡。在整个实验过程中,NTB和TB大鼠都避免饮用盐酸奎宁和盐酸溶液,这表明肿瘤生长并未干扰动物对这些正常厌恶味觉的感知。在两组中,对蔗糖(88%至97%)和糖精(75%至93%)的偏好分别在第22天和第17天之前一直很高,但随着肿瘤的进展而趋于下降。在这两种情况下,蔗糖或糖精偏好的变化之前,总热量摄入量的减少已经持续了几天。无论有无肿瘤,大鼠对氯化钠的偏好始终约为50%。在方案2中,在肿瘤植入前和3周后明显出现食物摄入量下降时,分别进行了四瓶偏好测试(蔗糖与糖精与氯化钠与水)。在测试前和测试后,TB和NTB大鼠对蔗糖的偏好均明显高于糖精、氯化钠和水。然而,对NTB和TB大鼠差异分数(植入前减去植入后)的比较显示,TB动物对蔗糖的偏好受到了轻微但显著的抑制。对甜味而非咸味刺激物偏好的改变表明,与食物相关的味觉线索在癌症期间可能更容易形成味觉厌恶。然而,味觉变化对癌症厌食症的影响仍不清楚,味觉偏好的变化可能是食物摄入量减少的继发结果。